Aspects of bleeding after cardiac surgery in children

Paediatric Anaesthesia

Volumn 17, Issue 12, 2007, Pages 1126-1133

  McEwan, Angus ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN III; APROTININ; CALCIUM; FIBRIN; FIBRIN GLUE; FIBRINOGEN; FIBRINOGEN RECEPTOR; FRESH FROZEN PLASMA; HEPARIN; HEPARIN LYASE; PLACEBO; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SEROTONIN; THROMBIN; THROMBOPLASTIN; TRANEXAMIC ACID;

ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CONGENITAL HEART DISEASE; CRYOPRECIPITATE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; FIBRINOLYSIS; HEART FAILURE; HEART INFARCTION; HEART SURGERY; HEMATOCRIT; HEMODILUTION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; PEDIATRIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STROKE; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOSIS; TREATMENT OUTCOME; ULTRAFILTRATION;

ANTIFIBRINOLYTIC AGENTS; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEMODILUTION; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; PEDIATRICS; POSTOPERATIVE HEMORRHAGE;

EID: 35848959489     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02265.x     Document Type: Review

References (61)

1. Chambers LA, Cohen DM, Davis JT. Transfusion patterns in pediatric open heart surgery. Transfusion 1996 36 : 150 154.
2. Petaja J, Lundstrom U, Leijala M et al. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995 109 : 524 529.
3. Lind SE, Marks PW, Ewenstein BM. Hemostatic system. In : Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology, 2nd edn. Philadelphia : Lippencott, Williams and Wilkins, 2003 : 959 981.
4. Williams MD, Chalmers EA, Gibson BE. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002 119 : 295 309.
5. Andrew M, Paes B, Milner R et al. Development of the human coagulation system in the full-term infant. Blood 1987 70 : 165 172.
6. Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998 24 : 507 512.
7. Richardson MW, Allen GA, Monahan PE. Thrombosis in children: current perspective and distinct challenges. Thromb Haemost 2002 88 : 900 911.
8. Monagle P, Michelson AD, Bovill E et al. Antithrombotic therapy in children. Chest 2001 119 (Suppl. 1 344S 370S.
9. Chan AK, Leaker M, Burrows FA et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass [erratum appears in Thromb Haemost 1997; 77: 1047]. Thromb Haemost 1977 77 : 270 277.
10. Guzzetta NA, Miller BE, Todd K et al. An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates. Anesth Analg 2005 100 : 1276 1282.
11. Guzzetta NA, Miller BE, Todd K et al. Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart disease. Anesth Analg 2006 103 : 1131 1138.
12. Kern FH, Morana NJ, Sears JJ et al. Coagulation defects in neonates during cardiopulmonary bypass [see comment]. Ann Thorac Surg 1992 54 : 541 546.
13. Miller BE, Mochizuki T, Levy JH et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997 85 : 1196 1202.
14. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999 89 : 57 64.
15. Williams GD, Bratton SL, Riley EC et al. Association between age and blood loss in children undergoing open heart operations. Ann Thorac Surg 1998 66 : 870 875 (discussion 875-876).
16. Guay J, Rivard GE. Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 1996 62 : 1955 1960.
17. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001 72 : S1821 S1831.
18. Saatvedt K, Lindberg H, Michelsen S et al. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children. Scand J Clin Lab Invest 1995 55 : 359 367.
19. Manno CS, Hedberg KW, Kim HC et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991 77 : 930 936.
20. Oliver WC Jr., Beynen FM, Nuttall GA et al. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg 2003 75 : 1506 1512.
21. Wedemeyer AL, Edson JR, Krivit W. Coagulation in cyanotic congenital heart disease. Am J Dis Child 1972 124 : 656 660.
22. Ekert H, Gilchrist GS, Stanton R et al. Hemostasis in cyanotic congenital heart disease. J Pediatr 1970 76 : 221 230.
23. Mauer HM, McCue CM, Caul J et al. Impairment in platelet aggregation in congenital heart disease. Blood 1972 40 : 207 216.
24. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost 1993 70 : 259 262.
25. Culliford AT, Gitel SN, Starr N et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg 1981 193 : 105 111.
26. Wachtfogel YT, Kettner C, Hack CE et al. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation. Thromb Haemost 1998 80 : 686 691.
27. Codispoti M, Ludlam CA, Simpson D et al. Individualized heparin and protamine management in infants and children undergoing cardiac operations. Ann Thorac Surg 2001 7 : 922 927 (discussion 927-928).
28. Gruenwald C, de Souza V, Chan AK et al. Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass. Perfusion 2000 15 : 203 209.
29. Jensen E, Andreasson S, Bengtsson A et al. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system. Ann Thorac Surg 2004 77 : 962 967.
30. Jensen E, Andreasson S, Bengtsson A et al. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery. Ann Thorac Surg 2003 75 : 919 925.
31. Levi M, Cromheecke ME, de JE et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999 354 : 1940 1947.
32. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass [Review; 99 refs]. Ann Thorac Surg 2001 71 : 745 754.
33. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 1997 85 : 1258 1267.
34. Karkouti K, Beattie WS, Dattilo KM et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006 46 : 327 338.
35. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006 354 : 353 365.
36. Mangano DT, Miao Y, Vuylsteke A et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007 297 : 471 479.
37. Hogue CW, London MJ. Aprotinin use during cardiac surgery: a new or continuing controversy? Anesth Analg 2006 103 : 1067 1070.
38. Arnold DM, Fergusson DA, Chan AK et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006 102 : 731 737.
39. Beath SM, Nuttall GA, Fass DN et al. Plasma aprotinin concentrations during cardiac surgery: full- versus half-dose regimens. Anesth Analg 2000 91 : 257 264.
40. Dietrich W, Mossinger H, Spannagl M et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations [see comment]. J Thorac Cardiovasc Surg 1993 105 : 712 20.
41. Mossinger H, Dietrich W. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage [Review; 24 refs]. Ann Thorac Surg 1998 65 (Suppl. 6 S45 50 (discussion S50-S51, S74-S76).
42. Boldt J, Knothe C, Zickmann B et al. Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood. Ann Thorac Surg 1993 55 : 1460 1466.
43. Boldt J, Knothe C, Zickmann B et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 1993 105 : 705 711.
44. Mossinger H, Dietrich W, Braun SL et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003 75 : 430 437.
45. Miller BE, Tosone SR, Tam VK et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998 66 : 535 540 (discussion 541).
46. Chauhan S, Kumar BA, Rao BH et al. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 2000 70 : 1308 1312.
47. Chauhan S, Bisoi A, Kumar N et al. Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2004 12 : 121 124.
48. Chauhan S, Das SN, Bisoi A et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004 18 : 141 143.
49. Rao BH, Saxena N, Chauhan S et al. Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Indian J Med Res 2000 111 : 57 61.
50. Reid RW, Zimmerman AA, Laussen PC et al. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997 84 : 990 996.
51. Friesen RH, Perryman KM, Weigers KR et al. A trial of fresh autologous whole blood to treat dilutional coagulopathy following cardiopulmonary bypass in infants. Pediatr Anesth 2006 16 : 429 435.
52. Journois D, Pouard P, Greeley WJ et al. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology 1994 81 : 1181 1189.
53. Codispoti M, Mankad PS. Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial. Eur J Cardiothorac Surg 2002 22 : 200 205.
54. Razon Y, Erez E, Vidne B et al. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Pediatr Anesth 2005 15 : 235 240.
55. Tobias JD, Simsic JM, Weinstein S et al. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med 2004 19 : 270 273.
56. Ekert H, Brizard C, Eyers R et al. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 2006 17 : 389 395.
57. Nuttall GA, Oliver WC, Ereth MH et al. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997 11 : 815 823.
58. Williams GD, Bratton SL, Riley EC et al. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999 13 : 398 404.
59. Martin P, Horkay F, Rajah SM et al. Monitoring of coagulation status using thrombelastography during paediatric open heart surgery. Int J Clin Monit Comput 1991 8 : 183 187.
60. Miller BE, Guzzetta NA, Tosone SR et al. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000 90 : 1324 1330.
61. Nuttall GA, Oliver WC, Santrach PJ et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001 94 : 773 781.